Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
Components necessary for hemostasis
|
Vessel wall/vascular endothelium
Platelets Plasma coagulation proteins Physiologic protease inhibitors Endogenous anticoagulants Fibrinolytic system |
|
Excess coagulation caused by disorders in ... (3)
|
Blood vessels
Coagulation and fibrinolytic factors Blood flow |
|
Excess bleeding caused by disorders in ... (3)
|
Platelets
Blood vessels Coagulation factors. |
|
5 phases of hemostasis
|
Primary hemostasis (platelet plug)
Secondary hemostasis (coagulation phase - formation of a fibrin clot) Fibrin formation/stabilization Termination of coagulation reactions Fibrinolysis |
|
Primary hemostasis
|
Vasoconstriction (reduce flow to injured area and allows procoag factors to localize)
and formation of platelet plug (requires von Willebrand factor, platelets, fibrinogen) |
|
von Willebrand Factor Synthesis
|
Synth in endothelial cells and megakaryocytes.
Post-trans multimerization. Multimers stored in Weibel-Palade bodies in endothelium and alpha granules in platelets. Cleaved into smaller multimers by ADAMTS13 |
|
vWF function
|
Tether platelets to subendothelium in vascular injury. (binds collagen on one side and platelets on the other via gp1b)
Support coagulation by chaperoning factor VIII (prolonging its half life and localizing it to the site of injury) Defiency --> bleeding disorder. |
|
Platelets
|
Anucleate cells - products of BM megakaryocytes.
Contain granules Lifespan - one week - 10 days Contains pro and anticoagulant proteins. |
|
Normal platelet numbers
|
150000-400000 per microliter.
|
|
Platelet activation
|
Pseudopods spread over subendothelium. (increased surface area)
Degranulation of alpha and dense granules Thromboxane A2 synthesis |
|
Alpha granules
|
In platelets,
PROTEINS Contains fibrinogen, vWF, factor V, other proteins |
|
Dense granules
|
In platelets,
SMALL MOLECULES Contains ADP, ATP, serotonin, calcium. |
|
Thromboxane A2 function
|
More vasoconstriction, platelet aggregation, platelet activation (feedback - because platelet activation is what synthesizes thromboxane A2.)
|
|
Platelet aggregation
|
Other platelets are recruited by activation products release.
GpIIb/IIIa on the platelet binds fibrinogen. On the other side of that fibrinogen is another gpiia/iiib. |
|
Phosphatidyl serine and phophatidyl ethanolamine
|
Allow coagulation factors to bind on platelet surface (referred to as platelet factor 3 (PF3) activity.
|
|
Defect in PF3 ability
|
Scott syndrome
|
|
Glanzmann thrombasthenia
|
Deficiency in GPIIb/IIIA receptor.
|
|
General function of secondary hemostasis
|
Form sturdy fibrin clot by...
Fibrin forming a mesh around platelets Stabilizing the platelet plug while the BV heals Enzyme cascade is activated to convery soluble fibrinogen to fibrin. |
|
Location of secondary hemostasis
|
Phospholipid surface (e.g. platelet membrane)
|
|
Which factors don't exist?
|
Factors IV or VI.
|
|
Coagulation factors - location of synthesis
|
In liver
exceptions - Factor VIII (liver AND vascular endothelium) Factor V - also in alpha granules in platelets. vWF - megakaryocytes and endothelial cells |
|
Vit K dependent coagulation factors
|
II, VII, IX, X. Also prot C and S
|
|
Endogenous anticoagulant factors
|
Proteins S, C, Z
|
|
Tissue factor
|
Expressed on cell surface by monocytes in response to vascular injury mainly, and also by damaged endothelial cells
Function - Complexes with factor VII to turn it into VIIa. Then these two directly catalyze X to Xa (direct) and also catalyze IX to IXa, which then catalyzes X to Xa in the presence of factor VIII and Ca++. Physiologic initiator of coagulation along with factor VIIa. |
|
Factor IX requirements to cleave X to Xa
|
Calcium and factor VIIIa (in her ppt she just says "factor VIII").
These two are needed to bind to the platelet membrane. And remember, VIII is in the area via vWF |
|
Xa function
|
Converts prothrombin (II) to thrombin (IIa) in the presence of Va.
V is stored IN platelets (alpha granules) and released at site of injury during platelet activation. |
|
Prothrombinase complex
|
Va anchors Xa and prothrombin (II) in close proximity on platelet phospholipid.
|
|
Thrombin - factor #
|
IIa
|
|
Thrombin - function
|
Catalyzes a small amount of fibrin monomer (Ia) from fibrinogen (I).
Feedback - activates XI to XIa (it is what converts IX to IXa - this is the thrombin burst [how most thrombin is made]). Also activates V and VIII. Activating XIII - to stabilize fibrin (turn it into cross-linked fibrin) Protects established clot (thrombus) from fibrinolysis. Inhibits coagulation when the time comes. |
|
Fibrinogen - synthesis locatin
|
Platelets secrete it.
|
|
Three sources of thrombin
|
Primary generation, amplification, propagation.
|
|
Hemophiliacs - Often what is their malfunction?
|
Can't perform thrombin burst (amplification).
|
|
Mechanism of Fibrinogen to Cross-linked fibrin
|
Thrombin cleaves FPA and FPB off of fibrinogen. XIIIa allows fibrin monomers to cross-link with each other.
|
|
Controlling coagulation
|
Hemodilution - Activated coag factors diluted by systemic circ.
Hepatic clearance - Activ coag factors cleared by the liver Endogenous anticoagulants Activated protein C/S Antithrombin (AKA antithrombin III) Tissue factor pathway inhibitor (TFPI) Protein Z Fibrinolysis via plasmin. |
|
Severe liver disease
|
May blood or clot too much because liver makes coagulation factors, but then also clears them away.
|
|
Antithrombin system
|
Inhibits Xa and thrombin - made in liver and endothelial cells - Heparin increases this activity
***(2-10 Hanna Heparin) |
|
Tissue factor pathway inhibitor
|
Produced by endothelial cells
Inhibits Xa Inhibits factor VIIa/TF with the help of Xa. |
|
Activated protein C/S system
|
S is the cofactor. Inhibits factor VIIIa and Va
Thrombin actually acting as an anticoagulant here because when thrombin bind thrombomodulin on the endothelial cell surface, thrombin changes shape (can't activate coag factors anymore) and protein C becomes activated. |
|
Fibrinolysis
|
Plasminogen synthesized by liver and circulates. Binds to fibrin,
cleaved to plasmin by plasminogen activators. (urokinase plasminogen activator or tissue plasminogen activator - UPA/TPA) Plasmin cleaves fibrin to release fibrin degradation products (D-dimers) |
|
Plasminogen activator inhibitor 1
|
Stored in platelets. Major inhibitor of tissue plasminogen activator (TPA).
|
|
Alpha-2-antiplasmin
|
Inhibitor of plasmin.
|
|
Bleeding disorders (overbleeding) due to deficiencies in...
|
Alpha-2-antiplasmin or Plasminogen activator inhibitor-1
|
|
ADP receptor
|
When bound, activates platelets.
|